Article Text

PDF
Cardiopulmonary exercise testing in children with cystic fibrosis: one centre's experience
  1. Elise Weir1,
  2. Paul D Burns2,
  3. Anne Devenny1,
  4. David Young3,
  5. James Y Paton4
  1. 1Department of Respiratory Paediatrics, Royal Hospital for Children, Glasgow, UK
  2. 2Department of Respiratory and Sleep Physiology, Royal Hospital for Children, Glasgow, UK
  3. 3Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK
  4. 4School of Medicine, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow, UK
  1. Correspondence to Dr Elise Weir, Department of Respiratory Paediatrics, Royal Hospital for Children, 1345 Govan Road, Glasgow G51 4TF, UK; elise_yu{at}doctors.org.uk

Abstract

Background While exercise testing is increasingly used as a prognostic indicator in cystic fibrosis (CF), it is reported to be underused in UK CF centres, particularly in children. Here, we evaluated the cardiopulmonary exercise testing (CPET) results in children and young people with CF at CF annual review and its possible clinical value.

Method An observational study comparing CPET results using a cycle ergometer ramp test (peak oxygen uptake (Vo2peak)) and pulmonary function (forced expiratory volume in 1 s (FEV1)) was performed with body mass index (BMI) used as a disease severity marker. Data were identified from clinical case notes and our CF database.

Results Thirty-eight children and young people (mean age 11±2.4, range 7–14 years; 17 males and 21 females) completed at least one CPET with 95% achieving technically satisfactory tests allowing measurement of Vo2peak. Mean Vo2peak was 107 ±17.6% predicted, range 74%–150% predicted, with 8% having a reduced Vo2peak of <85% of predicted. Mean FEV1 z-score was −0.77±1.24, range −4.42 to 2.24. We did not demonstrate a significant correlation between Vo2peak % predicted and FEV1 z-score (r=0.25, p=0.13), or between Vo2peak % predicted and BMI z-score (r=−0.05, p=0.77). Twenty-eight of 38 completed a second CPET the following year with 71% showing a decline in Vo2peak (mean decline of 8% of predicted value, equivalent to 3.8 mL/kg/min).

Conclusion CPET is feasible with 95% of children and young people achieving technically satisfactory assessments starting from age 7. In this group with relatively mild CF, mean Vo2peak was normal with no significant correlation between Vo2peak and FEV1 or BMI, as markers of disease severity. The majority demonstrated a normal Vo2peak. However, 71% showed a downward trend on repeat testing 12–18 months later.

  • Cystic Fibrosis
  • cardiopulmonary exercise testing
  • aerobic fitness
  • pulmonary function

Statistics from Altmetric.com

Footnotes

  • Contributors AD instigated, designed and supervised the study. EW and PDB contributed to the design of the study, collected the data and analysed results with DY. EW and PDB wrote the article. JYP reviewed and commented on the article.

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.